Fibronectin expression during physiological and pathological cardiac growth

F Farhadian, F Contard, A Corbier, A Barrieux… - Journal of molecular and …, 1995 - Elsevier
Fibronectin (FN) is a dimeric glycoprotein found in the extracellular matrix of most tissues
that serves as a bridge between cells and the interstitial collagen meshwork and influences …

Transgenic mice overexpressing human KvLQT1 dominant-negative isoform Part I: Phenotypic characterisation

…, I Baro, G Guihard, N Le Berre, A Corbier… - Cardiovascular …, 2001 - academic.oup.com
Objectives: The KCNQ1 gene encodes the KvLQT1 potassium channel, which generates in
the human heart the slow component of the cardiac delayed rectifier current, I Ks . Mutations …

Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated …

…, C Daveu, G Tavares, S Roy, A Corbier… - Cardiovascular …, 2020 - academic.oup.com
Aims Despite improvements in patient identification and management, heart failure (HF)
remains a major public health burden and an important clinical challenge. A variety of animal …

Evidence for two transient sodium currents in the frog node of Ranvier.

E Benoit, A Corbier, JM Dubois - The Journal of Physiology, 1985 - Wiley Online Library
Na current (INa) was monitored in isolated voltage‐clamped frog nodes of Ranvier in order
to analyse the pharmacological and kinetic properties of fast and slow phases of inactivation. …

Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (Imidazolylbiphenylyl) …

…, J Guillaume, R Becker, A Corbier… - Journal of medicinal …, 1995 - ACS Publications
The synthesis and pharmacological activity of new potent nonpeptide non-tetrazole
angiotensin II (All) receptor antagonists are described. These compounds are 4-thioimidazole …

Expression of laminin α2 chain during normal and pathological growth of myocardium in rat and human

…, C Chassagne, N Salichon, A Corbier… - Cardiovascular …, 2000 - academic.oup.com
Objectives: Fibrosis is a classical feature of cardiac hypertrophy. To date changes within the
basal lamina during normal and pathological cardiac growth have been poorly investigated. …

Identification of potent and long-acting single-chain peptide mimetics of human relaxin-2 for cardiovascular diseases

…, D Brasseur, P Bruneau, A Corbier… - Journal of Medicinal …, 2021 - ACS Publications
The insulin-like peptide human relaxin-2 was identified as a hormone that, among other
biological functions, mediates the hemodynamic changes occurring during pregnancy. …

R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases

…, O Pasquier, X Chenede, A Corbier… - British Journal of …, 2024 - Wiley Online Library
Background The therapeutic potential of relaxin for heart failure and renal disease in clinical
trials is hampered by the short half‐life of serelaxin. Optimization of fatty acid‐acetylated …

Oversulfated chondroitin sulfate and OSCS-contaminated heparin cause dose-and route-dependent hemodynamic effects in the rat

A Corbier, N Le Berre, D Rampe, H Meng… - Toxicological …, 2011 - academic.oup.com
During 2007–2008, serious adverse events were reported following iv administration of
certain batches of commercially available heparin in humans. Anaphylactoid reactions with …

[HTML][HTML] A G-protein-biased S1P1 agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome

…, AM Lefebvre, A Roccon, F Gillot, S Beeské, A Corbier… - Plos one, 2022 - journals.plos.org
Aim Heart failure with preserved ejection fraction (HFpEF) is a major cause of death worldwide
with no approved treatment. Left ventricular hypertrophy (LVH) and diastolic dysfunction …